Elicio Therapeutics Inc (ELTX)
9.86
-0.19
(-1.89%)
USD |
NASDAQ |
May 20, 16:00
9.77
-0.09
(-0.91%)
After-Hours: 20:00
Elicio Therapeutics Total Assets (Quarterly): 24.48M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.48M |
| December 31, 2023 | 27.15M |
| September 30, 2023 | 30.99M |
| Date | Value |
|---|---|
| June 30, 2023 | 37.62M |
| December 31, 2022 | 22.66M |
| March 31, 2021 | 19.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.12M
Minimum
Mar 2021
37.62M
Maximum
Jun 2023
27.00M
Average
25.81M
Median
Total Assets (Quarterly) Benchmarks
| Immuneering Corp | 87.98M |
| Outlook Therapeutics Inc | 59.03M |
| Amylyx Pharmaceuticals Inc | 417.46M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |